- Published on
Pharmacology - Dipyridamole
The action of dipyridamole
It prevents platelets from aggregating together.
Mode of Action
has vasodilator properties; inhibits the acquisition of adenosine by platelets and inhibits the action of cyclic GMP phosphodiesterase.
Orally administered, typically in the form of a modified release preparation.
Use in Clinical Settings
Used in conjunction with aspirin for the secondary prevention of transient ischaemic attacks and strokes caused by ischemic stroke.
Adverse Reactions
The most common symptoms are headache, gastrointestinal distress, hypotension, and hypersensitivity reactions.
The action of dipyridamole
It prevents platelets from aggregating together.
Mode of Action
has vasodilator properties; inhibits the acquisition of adenosine by platelets and inhibits the action of cyclic GMP phosphodiesterase.
Orally administered, typically in the form of a modified release preparation.
Use in Clinical Settings
Used in conjunction with aspirin for the secondary prevention of transient ischaemic attacks and strokes caused by ischemic stroke.
Adverse Reactions
The most common symptoms are headache, gastrointestinal distress, hypotension, and hypersensitivity reactions.
0 Comments
